Osaic Holdings’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.4K Sell
1,053
-5,407
-84% -$156K ﹤0.01% 5038
2025
Q1
$261K Buy
6,460
+5,352
+483% +$217K ﹤0.01% 3422
2024
Q4
$30.8K Buy
1,108
+8
+0.7% +$223 ﹤0.01% 5024
2024
Q3
$31.6K Hold
1,100
﹤0.01% 5046
2024
Q2
$25.8K Sell
1,100
-1,878
-63% -$44.1K ﹤0.01% 5125
2024
Q1
$75.2K Sell
2,978
-421
-12% -$10.6K ﹤0.01% 4442
2023
Q4
$79.4K Sell
3,399
-1,843
-35% -$43K ﹤0.01% 4583
2023
Q3
$265K Buy
5,242
+3,433
+190% +$174K ﹤0.01% 3783
2023
Q2
$84.5K Buy
1,809
+359
+25% +$16.8K ﹤0.01% 4561
2023
Q1
$55.5K Buy
1,450
+315
+28% +$12.1K ﹤0.01% 4869
2022
Q4
$62K Sell
1,135
-289
-20% -$15.8K ﹤0.01% 4771
2022
Q3
$48K Buy
1,424
+1,150
+420% +$38.8K ﹤0.01% 4920
2022
Q2
$3K Hold
274
﹤0.01% 6638
2022
Q1
$4K Sell
274
-723
-73% -$10.6K ﹤0.01% 6476
2021
Q4
$22K Buy
997
+112
+13% +$2.47K ﹤0.01% 5693
2021
Q3
$19K Hold
885
﹤0.01% 5789
2021
Q2
$22K Sell
885
-400
-31% -$9.94K ﹤0.01% 5579
2021
Q1
$37K Buy
+1,285
New +$37K ﹤0.01% 5057